For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Prednisolone (Glucocorticoid (intermediate-acting)) – indications: Acute asthma / COPD exacerbation – adults, Acute asthma – children, Croup (laryngotracheitis) – children, if dexamethasone p.o. is not possible. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Acute asthma / COPD exacerbation – adults
- Acute asthma – children
- Croup (laryngotracheitis) – children, if dexamethasone p.o. is not possible
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Global Initiative for Asthma (GINA). Summary Guide for Asthma Management and Prevention 2024. ginasthma.org.
- Bundesärztekammer, KBV, AWMF. Nationale VersorgungsLeitlinie Asthma.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD.
- Summaries of product characteristics of authorised products – product and section for each dose in the app.